HUMAN PAPILLOMA VIRUS (HPV)
Clinical trials for HUMAN PAPILLOMA VIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may let some throat cancer patients skip radiation after surgery
Disease control Recruiting nowThis study is for people with HPV-related throat cancer who have surgery to remove the tumor. Normally, some patients also get radiation afterward to lower the risk of cancer coming back. This trial tests whether it's safe to skip that radiation if a blood test two weeks after su…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier YCANTH wart studies. It tests whether up to 4 more treatments, applied every 21 days, can safely clear common warts. About 600 adults and children will be monitored for a year. The goal is to see if the medicine continues…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel can clear all warts by day 84.
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
At-Home HPV tests could boost cervical cancer screening in border communities
Prevention Recruiting nowThis study tests whether at-home HPV self-sampling (using urine or a vaginal swab) can help more people get screened for cervical cancer compared to the traditional in-clinic Pap smear. About 735 Latinx individuals aged 30-65 who haven't had a Pap test in at least three years wil…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Phase: NA • Sponsor: University of Texas at Austin • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Blood test could reveal if cervical cancer treatment is working
Knowledge-focused Recruiting nowThis study is testing two blood tests that look for HPV DNA and RNA to see if they can track how well cervical cancer responds to surgery, radiation, and chemotherapy. Researchers will enroll 55 adults with HPV-related cervical cancer and compare the test results with standard im…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
10,000 people tested: Cambodia's massive disease hunt begins
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for 57 different infectious diseases, including dengue, flu, and malaria. Researchers want to understand how these diseases spread and who is at risk. The goal is to give local health authorities the information they need to create b…
Matched conditions: HUMAN PAPILLOMA VIRUS (HPV)
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC